Top Markets
#1 Islamic Coin Islamic Coin +151.45%
#2 DOVU DOVU +50.49%
#3 Black Phoenix Black Phoenix +34.88%
#4 Velvet Velvet +32.10%
#5 Akedo Akedo +21.65%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.03%
#7 DoubleZero DoubleZero +15.69%
#8 Cross Cross +12.56%
#9 HOME HOME +12.51%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +12.12%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Asia Green Biotechnology Corp. Asia Green Biotechnology Corp.

Asia Green Biotechnology Corp.

ASIA
Rank in Stocks #39654
Asia Green Biotechnology Corp. is an emerging international biotechnology firm... Asia Green Biotechnology Corp. is an emerging international biotechnology firm dedicated to researching, developing, testing, and distributing products. These offerings leverage the company's proprietary organic hybridization technology, with its primary application focused in Asia. A key aspect of their operations involves the cultivation and harvesting of novel and commercially valuable strains of hemp and similar crops. The company has forged strategic alliances with Pathway Rx Inc. and PNW Biosciences Inc. to advance the clinical development and market introduction of specific Cannabis sativa varieties. These varieties are being explored for their potential in both preventing and treating COVID-19 and other infectious ailments. Established in 2017, the organization was originally named Asia Cannabis Corp. It adopted its current moniker, Asia Green Biotechnology Corp., in April 2020. Its corporate headquarters are located in Calgary, Canada.
Share Price
$0.01100905
Last synced: 2024-07-23
Market Cap
$399.05K
Change (1 day)
-0.24%
Change (1 year)
0.00%
Country
CA
Trade Asia Green Biotechnology Corp. (ASIA)

Category

Healthcare
Revenue for Asia Green Biotechnology Corp. (ASIA)
Revenue in Aug 2026 TTM: 0
According to Asia Green Biotechnology Corp. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Asia Green Biotechnology Corp. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN